Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 154

1.

Regression of benign melanocytic nevi ipilimumab-induced in an adult patient affected by metastatic melanoma: is it a sign of response to therapy?

Grassi S, Corsetti P, Moliterni E, Calvieri S.

G Ital Dermatol Venereol. 2019 May 14. doi: 10.23736/S0392-0488.19.06351-X. [Epub ahead of print] No abstract available.

PMID:
31104465
2.

Effectiveness of oral propranolol in a patient with neurofibromatosis type 1 and infantile hemangiomas.

Miraglia E, Schiavetti A, Varrasso G, Celli M, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2019 Mar 29. doi: 10.23736/S0392-0488.19.06179-0. [Epub ahead of print] No abstract available.

PMID:
30924624
3.

A case of Cowden syndrome associated with melanoma: the role of the dermatologist.

Roberti V, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2019 Feb 4. doi: 10.23736/S0392-0488.19.06272-2. [Epub ahead of print] No abstract available.

PMID:
30717572
4.

Melanoma in neurofibromatosis type 1: an Italian single center experience.

Miraglia E, Lopez T, Iacovino C, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2019 Feb;154(1):89-91. doi: 10.23736/S0392-0488.17.05612-7. No abstract available.

PMID:
30616334
5.

Correlation of serum tryptase levels with total number of nevi, Breslow thickness, ulceration, and mitotic index in melanoma patients: evaluation of a promising prognostic marker.

Crincoli E, Moliterni E, Catania F, Didona D, Calvieri S, Paolino G.

Melanoma Res. 2018 Dec 15. doi: 10.1097/CMR.0000000000000561. [Epub ahead of print]

PMID:
30557216
6.

Sequential treatment of daylight photodynamic therapy and imiquimod 5% cream for the treatment of superficial basal cell carcinoma on sun exposed areas.

Paolino G, Didona D, Scarnò M, Tallarico M, Cantoresi F, Calvieri S, Mercuri SR, Piccolo D, Bottoni U, Kyriakou A, Cantisani C.

Dermatol Ther. 2019 Mar;32(2):e12788. doi: 10.1111/dth.12788. Epub 2018 Dec 21. No abstract available.

PMID:
30499211
7.

Lipomas in Neurofibromatosis Type 1: a single-institution experience.

Miraglia E, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Oct 22. doi: 10.23736/S0392-0488.18.06044-3. [Epub ahead of print] No abstract available.

PMID:
30350556
8.

Two rare disease in the same patient: neurofibromatosis type 1 and Madelung's disease.

Miraglia E, Fino P, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Oct 3. doi: 10.23736/S0392-0488.18.06166-7. [Epub ahead of print] No abstract available.

PMID:
30295449
9.

Nevus spilus in neurofibromatosis type 1: a single center experience.

Miraglia E, Fino P, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Oct 3. doi: 10.23736/S0392-0488.18.06088-1. [Epub ahead of print] No abstract available.

PMID:
30295445
10.

Sequential methyl-aminolevulinate daylight photodynamic therapy and diclofenac plus hyaluronic acid gel treatment for multiple actinic keratosis evaluation.

Cantisani C, Paolino G, Scarnò M, Didona D, Tallarico M, Moliterni E, Losco L, Cantoresi F, Mercuri SR, Bottoniτ U, Calvieri S.

Dermatol Ther. 2018 Nov;31(6):e12710. doi: 10.1111/dth.12710. Epub 2018 Sep 25. No abstract available.

PMID:
30253027
11.

Giant plexiform neurofibroma in neurofibromatosis type 1.

Miraglia E, Lopez T, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Oct;153(5):740-741. doi: 10.23736/S0392-0488.17.05678-4. No abstract available.

PMID:
30246960
12.

Prognostic correlation between vitamin D serological levels, Body Mass Index and clinical-pathological features in melanoma patients.

Moliterni E, Paolino G, Veronese N, Bottoni U, Corsetti P, Cardone M, Didona D, Lopez T, Calvieri S.

G Ital Dermatol Venereol. 2018 Oct;153(5):732-733. doi: 10.23736/S0392-0488.17.05652-8. No abstract available.

PMID:
30246955
13.

Metastases risk in thin cutaneous melanoma: prognostic value of clinical-pathologic characteristics and mutation profile.

Richetta AG, Valentini V, Marraffa F, Paolino G, Rizzolo P, Silvestri V, Zelli V, Carbone A, Di Mattia C, Calvieri S, Frascione P, Donati P, Ottini L.

Oncotarget. 2018 Aug 14;9(63):32173-32181. doi: 10.18632/oncotarget.25864. eCollection 2018 Aug 14.

14.

Neurodystrophic Hand Dermatitis: Sannino Barduagni Syndrome.

Bottoni U, Tamburrini S, Scali E, Dastoli S, Amoruso GF, Paolino G, Moliterni E, Grieco T, Pranteda G, Calvieri S.

Acta Dermatovenerol Croat. 2017 Dec;25(4):312-313.

PMID:
30064610
15.

PIK3CA c.3140A>G mutation in a patient with suspected Proteus Syndrome: a case report.

Valentini V, Zelli V, Rizzolo P, Silvestri V, Alimandi M, D'Aloia MM, Giustini S, Calvieri S, Richetta AG, Monteleone G, Ottini L.

Clin Case Rep. 2018 Jun 2;6(7):1358-1363. doi: 10.1002/ccr3.1546. eCollection 2018 Jul.

16.

Pseudoxanthoma elasticum in Italy: epidemiological and clinical aspects.

Miraglia E, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Jun 29. doi: 10.23736/S0392-0488.18.06076-5. [Epub ahead of print] No abstract available.

PMID:
29963809
17.

Lipomatosis of the caregiver: a new form of cutaneous lipomatosis.

Miraglia E, Fino P, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Jun 29. doi: 10.23736/S0392-0488.18.06055-8. [Epub ahead of print] No abstract available.

PMID:
29963805
18.

Nasopharyngeal Melanoma.

Paolino G, Didona D, Macrì G, Calvieri S, Mercuri SR.

In: Scott JF, Gerstenblith MR, editors. Noncutaneous Melanoma [Internet]. Brisbane (AU): Codon Publications; 2018 Mar. Chapter 4.

19.

Anorectal Melanoma.

Paolino G, Didona D, Macrì G, Calvieri S, Mercuri SR.

In: Scott JF, Gerstenblith MR, editors. Noncutaneous Melanoma [Internet]. Brisbane (AU): Codon Publications; 2018 Mar. Chapter 6.

20.

Poliosis circumscripta in association with neurofibromatosis type 1: only a coincidence?

Miraglia E, Roberti V, Lopez T, Iacovino C, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 May 16. doi: 10.23736/S0392-0488.18.05882-0. [Epub ahead of print] No abstract available.

PMID:
29781260

Supplemental Content

Loading ...
Support Center